Teva Executive and Leadership Team

Vitaliy Gayduchenko, the Chief Financial Officer at Teva, directs the company's overall financial strategy and operations. This leadership role involves managing Teva's global financial health, ensuring fiscal responsibility, and optimizing resource allocation across all business units. Gayduchenko oversees budgeting, forecasting, and financial reporting, providing critical insights that inform strategic decision-making. The Chief Financial Officer's responsibilities extend to managing investor relations and capital structure, vital for sustaining Teva's position as a global biopharmaceutical leader. Vitaliy Gayduchenko's financial acumen supports the company's mission to improve health outcomes by enabling the development and delivery of a broad portfolio of medicines, from complex generics to innovative therapies. This executive ensures financial stability, underpinning Teva's dedication to addressing unmet patient needs through scientific research and expanded access to quality treatments.

Yehuda Koren, the Director, Financial & Chief Financial Officer, S L E at Teva, manages specific financial operations and strategic initiatives within the company's Special Legal Entity (SLE) framework. This role demands a deep understanding of complex financial structures and regulatory environments pertinent to Teva's global biopharmaceutical operations. Koren oversees financial planning, analysis, and reporting for the designated S L E, ensuring alignment with broader corporate financial objectives. The Director, Financial & Chief Financial Officer, S L E plays a crucial part in optimizing financial performance and mitigating risks associated with specialized business segments. Yehuda Koren's financial oversight contributes directly to Teva's ability to deliver a diverse range of medicines, including complex generics and innovative therapies, thereby supporting the company's overarching goal of improving patient health outcomes worldwide.

Efrat Yehudai, the Senior Vice President, Chief Financial Officer ) Teva Global Operations( ( Tech Operations) at Teva, directs financial strategy and oversight for Teva's global technology and operations divisions. This critical role involves managing the financial health and performance of Teva's extensive manufacturing and technological infrastructure, ensuring efficient resource allocation and fiscal discipline. Yehudai oversees budgeting, forecasting, and financial analysis specifically for global operations and tech operations, providing essential data for strategic planning and investment decisions. The Senior Vice President, Chief Financial Officer's responsibilities are key to supporting Teva's commitment to developing, manufacturing, and delivering a broad portfolio of medicines. Efrat Yehudai's financial leadership ensures operational excellence, enabling Teva to advance scientific research and expand access to quality treatments worldwide.

Eli Kalif, the Chief Financial Officer & Executive VP at Teva, holds comprehensive responsibility for the company's global financial strategy and execution. This executive leadership position involves overseeing all aspects of financial planning, management, and reporting, ensuring fiscal integrity and driving sustainable growth. Kalif directs capital allocation, risk management, and investor relations, providing strategic financial guidance that supports Teva's mission to improve patient outcomes. The Chief Financial Officer & Executive VP's purview extends to optimizing financial performance across Teva's diverse portfolio, including complex generics, biosimilars, and innovative therapies. Eli Kalif's financial leadership is instrumental in advancing scientific research, expanding access to quality medicines, and ensuring the efficient delivery of treatments from established generics to cutting-edge solutions.

Craig Olson, the Chief Financial Officer, Operations at Teva, provides dedicated financial leadership and strategic oversight for the company's extensive operational divisions. This executive role involves managing the financial performance of Teva's manufacturing, supply chain, and operational infrastructure, ensuring cost-efficiency and robust financial controls. Olson oversees budgeting, financial analysis, and resource allocation specifically for operational activities, supporting the seamless production and delivery of Teva's broad medicine portfolio. The Chief Financial Officer, Operations's focus is critical for maintaining the integrity of Teva's supply chain and manufacturing processes. Craig Olson's financial expertise underpins Teva's commitment to advancing scientific research and expanding access to quality medicines, thereby enhancing global health outcomes.

Efi Benmeir, the Senior VP, Finance & Chief Financial Officer, International Markets at Teva, directs financial strategy and operations across Teva's global markets outside of its primary domestic operations. This leadership position involves managing financial planning, analysis, and reporting for diverse international regions, ensuring fiscal compliance and driving profitable growth. Benmeir oversees capital deployment and financial risk management within these international territories, supporting Teva's broad portfolio of medicines. The Senior VP, Finance & Chief Financial Officer's role is essential for adapting Teva's financial strategies to varied market conditions and regulatory landscapes. Efi Benmeir's financial acumen strengthens Teva's ability to expand access to quality treatments and address unmet patient needs worldwide.

Fernando Rodrigo, the Director, Finance & Chief Financial Officer at Teva, manages key financial functions and strategic financial planning within specific segments of the company. This role requires meticulous oversight of financial operations, ensuring accuracy in reporting and efficiency in resource utilization. Rodrigo oversees budgeting, forecasting, and financial analysis, providing critical data to support Teva's broader business objectives and its mission to improve patient health. The Director, Finance & Chief Financial Officer's responsibilities are integral to maintaining the financial health of the business units under purview. Fernando Rodrigo's financial management contributes to Teva's capacity to develop, manufacture, and deliver a wide array of medicines, supporting the company's dedication to scientific advancement and expanded access to quality treatments.

Dov Primovitch, the Chief Financial Officer (Israel) at Teva, leads financial strategy and operations specifically within the Israeli market. This executive role involves managing all aspects of financial planning, budgeting, and reporting for Teva's operations in Israel, ensuring fiscal responsibility and compliance with local regulations. Primovitch oversees capital allocation and financial risk management within the Israeli context, supporting the delivery of Teva's broad portfolio of medicines. The Chief Financial Officer (Israel)'s focus is crucial for optimizing financial performance and contributing to Teva's global mission. Dov Primovitch's financial leadership strengthens Teva's ability to address unmet patient needs and expand access to quality treatments within its home market and beyond.

Martin Laughlin, the Chief of Staff and Head of Commercial Excellence at Teva, drives strategic initiatives to enhance commercial operations and operational efficiency across the organization. This position involves coordinating cross-functional efforts, streamlining processes, and implementing best practices to maximize market reach and impact. Laughlin oversees the development and execution of commercial excellence programs, ensuring Teva's sales and marketing teams operate at peak performance. The Chief of Staff and Head of Commercial Excellence role is pivotal in translating Teva's mission into actionable commercial strategies, supporting the delivery of a broad portfolio of medicines. Martin Laughlin's leadership ensures that Teva effectively addresses unmet patient needs by optimizing the delivery of treatments and advancing scientific research, contributing significantly to the company's global health objectives.

Alicia Logan, the Chief of Staff & Senior Director, Commercial Excellence at Teva, spearheads initiatives to elevate commercial performance and operational effectiveness. This role focuses on refining sales strategies, enhancing customer engagement, and implementing best practices across Teva's commercial functions. Logan directs programs designed to foster commercial excellence, ensuring alignment with market demands and corporate objectives. The Chief of Staff & Senior Director, Commercial Excellence position is vital for translating Teva's commitment to improving health outcomes into tangible market success. Alicia Logan's efforts contribute directly to Teva's ability to deliver a broad portfolio of medicines, supporting the company's dedication to addressing unmet patient needs and advancing scientific research globally.